<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045256"><TermName>interleukin-2</TermName><TermPronunciation>(in-ter-LOO-kin...)</TermPronunciation><TermDefinition><DefinitionText>One of a group of related proteins made by leukocytes (white blood cells) and other cells in the body. Interleukin-2 is made by a type of T lymphocyte. It increases the growth and activity of other T lymphocytes and B lymphocytes, and affects the development of the immune system. Aldesleukin (interleukin-2 made in the laboratory) is being used as a biological response modifier to boost the immune system in cancer therapy. Interleukin-2 is a type of cytokine.  Also called IL-2.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705213" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;interleukin-2&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705212" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;interleucina-2&quot;" language="es" id="_4"/><SpanishTermName>interleucina-2</SpanishTermName><SpanishTermDefinition><DefinitionText>Pertenece a un grupo de proteínas relacionadas que elaboran los leucocitos (glóbulos blancos) y otras células del cuerpo. Los linfocitos T elaboran la interleucina-2. Aumenta el crecimiento y la actividad de otros linfocitos T y B, y afecta el desarrollo del sistema inmunitario. La aldesleucina (interleucina-2 que se produce en el laboratorio) se usa en el tratamiento de cáncer como modificador de la respuesta biológica para estimular el sistema inmunitario. La interleucina-2 es un tipo de citocina.   También se llama IL-2.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2008-11-11</DateLastModified></GlossaryTerm>
